Mark Dudley

Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infiltrating lymphocytes

A. Udyavar, Eric H. Gschweng, S. Sukumaran, 2023, Frontiers in immunology.